We evaluated the access to, and the factors associated with, protease inhibitor use among persons with AIDS in Los Angeles County.
A population-based sample of adult persons with AIDS is routinely interviewed in Los Angeles County and includes a 30% random sample of men who have sex with men and all other persons reported with AIDS.
Since May of 1996, all participants were asked if their physician had ever prescribed a protease inhibitor for their use.
The possible association between protease inhibitor use and sociodemographic, temporal and health care factors was assessed for the 12-month period May 1996 through April 1997.
Logistic regression was employed for multivariate analysis.
Over the 12-month study period, 61.7% (209/339) persons interviewed reported that their physician had prescribed a protease inhibitor as part of their therapy.
In bivariate analysis, treatment with protease inhibitor use was more common for whites (71.4%) and US-born Latinos (68.2%) than blacks (53.4%) and foreign-born Latinos (56.6%), among person of higher income (71.2%) than lower (<$10,000) income (50.3%), in those who reported having insurance (66. 7%) than those uninsured (47%) and among persons receiving care at private clinics (86.4%) than at HMOs (63.4%) or public clinics (55.2%). An increasing trend of protease inhibitor use with higher educational level and declining CD4+count was observed. (...)
Mots-clés Pascal : SIDA, Virose, Infection, Prescription médicale, Inhibiteur protease, Service santé, Etats Unis, Amérique du Nord, Amérique, Accessibilité, Homme, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Medical prescription, Protease inhibitor, Health service, United States, North America, America, Accessibility, Human, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0255363
Code Inist : 002B30A03A. Création : 16/11/1999.